JP2014516530A5 - - Google Patents

Download PDF

Info

Publication number
JP2014516530A5
JP2014516530A5 JP2014511717A JP2014511717A JP2014516530A5 JP 2014516530 A5 JP2014516530 A5 JP 2014516530A5 JP 2014511717 A JP2014511717 A JP 2014511717A JP 2014511717 A JP2014511717 A JP 2014511717A JP 2014516530 A5 JP2014516530 A5 JP 2014516530A5
Authority
JP
Japan
Prior art keywords
canine influenza
virus
gene
seq
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014511717A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014516530A (ja
Filing date
Publication date
Priority claimed from CN2011101395283A external-priority patent/CN102220293B/zh
Application filed filed Critical
Publication of JP2014516530A publication Critical patent/JP2014516530A/ja
Publication of JP2014516530A5 publication Critical patent/JP2014516530A5/ja
Pending legal-status Critical Current

Links

JP2014511717A 2011-05-26 2012-04-26 イヌインフルエンザ組み換えウイルス及びその製造方法、並びにその応用 Pending JP2014516530A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2011101395283A CN102220293B (zh) 2011-05-26 2011-05-26 犬流感重组病毒及其制备方法和应用
CN201110139528.3 2011-05-26
PCT/CN2012/074722 WO2012159522A1 (zh) 2011-05-26 2012-04-26 犬流感重组病毒及其制备方法和应用

Publications (2)

Publication Number Publication Date
JP2014516530A JP2014516530A (ja) 2014-07-17
JP2014516530A5 true JP2014516530A5 (OSRAM) 2015-04-23

Family

ID=44776999

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014511717A Pending JP2014516530A (ja) 2011-05-26 2012-04-26 イヌインフルエンザ組み換えウイルス及びその製造方法、並びにその応用

Country Status (7)

Country Link
US (1) US20140286979A1 (OSRAM)
EP (1) EP2716752A4 (OSRAM)
JP (1) JP2014516530A (OSRAM)
KR (1) KR20140031912A (OSRAM)
CN (1) CN102220293B (OSRAM)
CA (1) CA2837126A1 (OSRAM)
WO (1) WO2012159522A1 (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102220293B (zh) * 2011-05-26 2012-12-19 中国农业科学院上海兽医研究所 犬流感重组病毒及其制备方法和应用
CN103881983B (zh) * 2014-03-07 2016-08-31 中国农业科学院哈尔滨兽医研究所 重组犬流感病毒毒株、其制备方法及由其制备得到的疫苗
KR101633489B1 (ko) 2015-02-25 2016-06-27 고패스 주식회사 통풍수단이 구비된 신발의 사출식 제조방법
WO2016210083A2 (en) 2015-06-26 2016-12-29 Merial, Inc. Inactivated canine influenza vaccines and methods of making and uses thereof
CN105647877A (zh) * 2016-02-02 2016-06-08 南京农业大学 一株低毒力重组猪脑心肌炎病毒及其应用
CN107602697B (zh) * 2017-08-29 2020-05-05 杭州医学院 一种治疗流感嗜血杆菌引起鼻窦炎的血清及该血清的应用
CN113173976B (zh) * 2021-06-03 2022-07-12 北京市农林科学院 一种犬流感病毒h3亚型ha蛋白、其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE368729T1 (de) * 1999-04-06 2007-08-15 Wisconsin Alumni Res Found Rekombinante influenzaviren zur vakzinherstellung und gentherapie
CN1261564C (zh) * 2003-12-02 2006-06-28 中国农业科学院哈尔滨兽医研究所 人工重组的流感病毒及其应用
US7384642B2 (en) * 2005-08-25 2008-06-10 Merial Limited Canine influenza vaccines
KR101597534B1 (ko) * 2005-10-19 2016-02-26 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 개과 동물의 호흡기 질병 조절을 위한 물질들 및 방법들
JP2010539093A (ja) * 2007-09-10 2010-12-16 インターベツト・インターナシヨナル・ベー・ベー イヌ、ネコ及びウマにおけるインフルエンザ感染を予防するための組成物及び方法
KR100850545B1 (ko) * 2007-10-30 2008-08-05 주식회사 에니멀제네틱스 신규한 개 인플루엔자 바이러스 및 이의 백신
CN102220293B (zh) * 2011-05-26 2012-12-19 中国农业科学院上海兽医研究所 犬流感重组病毒及其制备方法和应用

Similar Documents

Publication Publication Date Title
JP2014516530A5 (OSRAM)
Xiao et al. PB2-588 V promotes the mammalian adaptation of H10N8, H7N9 and H9N2 avian influenza viruses
Noda et al. Structure of influenza virus ribonucleoprotein complexes and their packaging into virions
Kamal et al. Molecular determinants of influenza virus pathogenesis in mice
Zhu et al. Mammalian-adaptive mutation NP-Q357K in Eurasian H1N1 Swine Influenza viruses determines the virulence phenotype in mice
JP2012519484A5 (OSRAM)
Arai et al. Novel polymerase gene mutations for human adaptation in clinical isolates of avian H5N1 influenza viruses
RU2008101367A (ru) Способы и композиции для экспрессии отрицательной смысловой вирусной рнк в собачьих клетках
JP2014506785A5 (OSRAM)
PT1831357E (pt) Obtenção de vírus da gripe
JP2009297040A5 (OSRAM)
CN104073513B (zh) 甲型流感病毒疫苗哺乳动物细胞适应株的获得方法和适应位点
CN104232594B (zh) 重组类禽型h1n1流感病毒灭活疫苗株(js40/pr8)及其制备方法和应用
Wang et al. Generation of a live attenuated influenza vaccine that elicits broad protection in mice and ferrets
Memoli et al. Recent human influenza A/H3N2 virus evolution driven by novel selection factors in addition to antigenic drift
KR102277763B1 (ko) 개선된 바이러스 생산을 위한 조류 세포
Looi et al. How far have we reached in development of effective influenza vaccine?
Xu et al. Genomic signature analysis of the recently emerged highly pathogenic A (H5N8) avian influenza virus: Implying an evolutionary trend for bird-to-human transmission
CN103118704B (zh) 经修饰的病毒株及用于改善流感病毒的疫苗种子的产生的方法
Sun et al. Evolution of the PB1 gene of human influenza A (H3N2) viruses circulating between 1968 and 2019
CN104592367A (zh) 流感病毒np蛋白突变体及其编码基因与应用
Suphaphiphat et al. Mutations at positions 186 and 194 in the HA gene of the 2009 H1N1 pandemic influenza virus improve replication in cell culture and eggs
JP2010183921A5 (OSRAM)
JP2020532283A (ja) インフルエンザワクチン用のウイルスシードストックの製造方法、前記シードストックを用いたインフルエンザワクチンの製造方法及び前記方法で製造したウイルスのシードストック
Zhang et al. Genetic characterization and pathogenesis of avian influenza virus H3N8 isolated from Chinese pond heron in China in 2021